Evidence map›Paper›PMID 29707774›Full record

ArticleBritish journal of haematology2018

Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes.

Susan K Parsons, Michael J Kelly, Joshua T Cohen, Sharon M Castellino, Tara O Henderson, Kara M Kelly, Frank G Keller, Tobi J Henzer, Anita J Kumar, Peter Johnson and 5 more

Open access · hybridAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Review
  3. Management of limited-stage Hodgkin lymphoma.Hematology. American Society of Hematology. Education Program · 2023
    Article
  4. Article
  5. Hodgkin lymphoma survivor perspectives on their engagement in treatment decision-making and discussion of late effects.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  6. Review
  7. Continuum of Care for Hodgkin Lymphoma: Impact of Modern Therapy on Postacute Morbidity and Mortality.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020
    Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 4 countries.

Susan K ParsonsDepartment of Pediatrics, Tufts University School of Medicine, Boston, MA, USA.
Michael J KellyDepartment of Pediatrics, Tufts University School of Medicine, Boston, MA, USA.
Joshua T CohenDepartment of Medicine, Tufts University School of Medicine, Boston, MA, USA.
Sharon M CastellinoAflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA.
Tara O HendersonDepartment of Pediatrics, Section of Hematology, Oncology and Stem Cell Transplantation, University of Chicago, Chicago, IL, USA.
Kara M KellyDepartment of Pediatrics, Roswell Park Cancer Institute, University of Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY, USA.
Frank G KellerAflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA.
Tobi J HenzerInstitute for Clinical Research and Health Policy Studies, Tufts MC, Boston, MA, USA.
Anita J KumarDepartment of Medicine, Tufts University School of Medicine, Boston, MA, USA.
Peter JohnsonCancer Research UK Centre, Southampton, UK.
Ralph M MeyerDepartment of Oncology, Juravinski Hospital and Cancer Centre and McMaster University, Hamilton, ON, Canada.
John RadfordUniversity of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
John RaemaekersDepartment of Haematology, Radboud University Medical Centre, Nijmegen, the Netherlands.
David C HodgsonRadiation Medicine Programme, University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Andrew M EvensDivision of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.ORCID 0000-0002-6900-1824
Tufts University · USEmory University · USCancer Research UK · GBJuravinski Hospital · CAManchester Academic Health Science Centre · GBRadboud University Nijmegen · NLRoswell Park Comprehensive Cancer Center · USRutgers, The State University of New Jersey · USUniversity of Chicago · USUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We developed a novel simulation model integrating multiple data sets to project long-term outcomes with contemporary therapy for early-stage Hodgkin lymphoma (ESHL), namely combined modality therapy (CMT) versus chemotherapy alone (CA) via

Indexed as

Computer SimulationAdultAntineoplastic AgentsDisease-Free SurvivalFemaleHodgkin DiseaseHumansMalePrognosisRecurrenceAntineoplastic Agentsdecision makinghealth-related quality of lifeHodgkin lymphomalate effects of therapysimulation modelling

Identifiers

PMID29707774
PMCPMC6055753
OpenAlexW2799318639

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.